Gamal Hussein
South College School of Pharmacy, USA
Biography
Gamal Hussein is a Professor of Pharmacy and Director of Interprofessional Education. He has completed a Doctoral of Pharmacy and two Fellowships at the University of Texas and the University of California, San Francisco. His research led to the identification of therapeutic window for felbamate, topiramate and lamotrigine as well as the identification of drug reactions/interactions such as gabapentin-felbamate drug interaction, and propofol-induced dystonia. Tequin (gatifloxacin) was discontinued from the market after his and others’ findings on its potential to cause hypoglycemia. He received the “Innovation in Teaching” award from the American Association of Colleges of Pharmacy and the “Health-Systems Practitioner” award from the National Pharmaceutical Association.